Scleroderma

Top Story

Consensus treatment plans streamline therapy, outcomes for pediatric rheumatic diseases

Consensus treatment plans streamline therapy, outcomes for pediatric rheumatic diseases
January 15, 2018
In the Journals

Long-term remission infrequent in mixed connective tissue disease

January 11, 2018
Data published in Arthritis Research and Therapy suggest that mixed connective tissue disease is a relatively stable disease with infrequent periods of long-term…
In the Journals

Stem cell transplant improves overall, event-free survival in scleroderma

January 3, 2018
Myeloablative autologous stem cell transplantation improved long-term clinical outcomes, including overall survival and event-free survival, among patients with diffuse…
In the Journals

Lung disease greatly increases costs for patients with scleroderma

December 7, 2017
For patients with systemic sclerosis, interstitial lung disease and pulmonary arterial hypertension can result in significant increases in health care costs, according…
More Headlines »
CME CE CE

Diagnosis and Treatment of Pemphigus Vulgaris: Strategies for Optimal Multidisciplinary Care

This activity is supported by an educational grant from Genentech, Inc.

This activity begins with a review of the presentation and diagnosis of pemphigus vulgaris, a rare but serious…
More »
Video
Meeting News

VIDEO: A1 polymorphism linked to atherosclerosis

December 15, 2016
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CPE CME

But How Similar is it? What You Need to Know and What to Tell Your Patients about Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will…
More »